Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 9Terminated 3Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Colorectal Neoplasms 8Breast Neoplasms 8Esophageal Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Carcinoma, Hepatocellular 6Glioblastoma 5Brain Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Colonic Neoplasms 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Lymphatic Metastasis 3Glioma 3Endometrial Neoplasms 3Disease 3Astrocytoma 3Thyroid Neoplasms 2Recurrence 2Pain, Postoperative 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2

Interventions

Temozolomide 7Radiotherapy 5Vincristine 3Cisplatin 3Carmustine 3Carboplatin 3Methotrexate 2Cyclophosphamide 2Chlorotoxin 2lonafarnib 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Metabolism 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Gelclair 1Etoposide 1Ethanol 1Arsenic Trioxide 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oligodendroglioma × Surgical Procedures, Operative × Clear all
NCT01637753 2012-07-11

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase NA Unknown
212 enrolled
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡